Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Multitherapy for diabetes.

× No keyword cloud information.

7 in total

1. Can diabetes management programs create sustained improvements in disease outcomes?

Authors: Russell L Rothman; Tom A Elasy
Journal: CMAJ Date: 2005-12-06 Impact factor: 8.262

2. Efficacy of intensive multitherapy for patients with type 2 diabetes mellitus: a randomized controlled trial.

Authors: Julie Ménard; Hélène Payette; Jean-Patrice Baillargeon; Pierre Maheux; Serge Lepage; Daniel Tessier; Jean-Luc Ardilouze
Journal: CMAJ Date: 2005-11-17 Impact factor: 8.262

3. Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT).

Authors:
Journal: JAMA Date: 2002-12-18 Impact factor: 56.272

4. Secondary prevention by raising HDL cholesterol and reducing triglycerides in patients with coronary artery disease.

Authors:
Journal: Circulation Date: 2000-07-04 Impact factor: 29.690

5. Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial.

Authors: A Keech; R J Simes; P Barter; J Best; R Scott; M R Taskinen; P Forder; A Pillai; T Davis; P Glasziou; P Drury; Y A Kesäniemi; D Sullivan; D Hunt; P Colman; M d'Emden; M Whiting; C Ehnholm; M Laakso
Journal: Lancet Date: 2005-11-26 Impact factor: 79.321

6. The Helsinki Heart Study: an 8.5-year safety and mortality follow-up.

Authors: J K Huttunen; O P Heinonen; V Manninen; P Koskinen; T Hakulinen; L Teppo; M Mänttäri; M H Frick
Journal: J Intern Med Date: 1994-01 Impact factor: 8.989

7. W.H.O. cooperative trial on primary prevention of ischaemic heart disease using clofibrate to lower serum cholesterol: mortality follow-up. Report of the Committee of Principal Investigators.

Authors:
Journal: Lancet Date: 1980-08-23 Impact factor: 79.321

7 in total